An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors

Phase 1

Active, not recruiting

• Conditions: Carcinoid Syndrome; Carcinoid Tumor; Digestive System Neuroendocrine Tumor G1; Metastatic Carcinoid Tumor

• Registration Number: NCT04993261
• Lead Sponsor: M.D. Anderson Cancer Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-7-21
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 71

Inclusion Criteria

Inclusion Criteria:<br><br> - Patients with: clinical features of carcinoid syndrome (or) increased serum and<br> urinary markers suggestive of carcinoid (or) endoscopic biopsy proven carcinoid (or)<br> metastases which are biopsy proven as carcinoid.<br><br> - Patient is scheduled to have a clinically indicated staging CT exam.<br><br> - Patients who have signed their informed consent form to undergo the study.<br><br>Exclusion Criteria:<br><br> - Patients who have already had their primary GI carcinoid resected.<br><br> - Contraindication to intravenous contrast agents (e.g. allergy, renal failure,<br> dialysis, pregnancy etc.).<br><br> - Pregnant patients.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sensitivity and specificity of dual energy computed tomography in detecting primary gastrointestinal carcinoid tumors